Ascentage Pharma's EBIT loss and liabilities compared to cash and near-term receivables raise debt usage concerns. The company's stock position appears risky after burning through CN¥814m of cash in a year.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
ASCENTAGE-B Stock Forum
ASCO 2025 Oral Presentation: Breakthrough Cancer Drug Results for Myeloid Malignancies and ACC Treatment
Two Novel Cancer Drugs Make Landmark Entry into CSCO Guidelines: China's First Bcl-2 Inhibitor Breakthrough
Cancer Research Breakthrough: Ascentage's 5 New Drug Studies Show Promise in Leukemia and Lung Cancer
Major Leukemia Treatment Breakthrough: Will This Drug Transform Ph+ ALL Therapy?
No comment yet